Source link : https://newshealth.biz/health-news/oral-fgfr1-3-inhibitor-boosted-height-velocity-in-common-genetic-growth-disorder/
Achondroplasia — the most common form of dwarfism — is caused by pathogenic gain-of-function variants in the gene encoding fibroblast growth factor receptor 3. Treatment with the oral tyrosine kinase inhibitor infigratinib led to significant increases in growth among children with achondroplasia in the phase III PROPEL 3 study. The once-daily capsule targets FGFR1-3 and […]
The post Oral FGFR1-3 Inhibitor Boosted Height Velocity in Common Genetic Growth Disorder first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-28 20:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8